scholarly journals Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy

2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Tobias Gerhard ◽  
Joseph AC Delaney ◽  
Rhonda M Cooper-DeHoff ◽  
Jonathan Shuster ◽  
Babette A Brumback ◽  
...  
2009 ◽  
Vol 51 (5) ◽  
pp. 789-800 ◽  
Author(s):  
Masahiro Sugihara ◽  
Toshio Kushiro ◽  
Ikuo Saito ◽  
Yasuyuki Matsushita ◽  
Katsutoshi Hiramatsu

Author(s):  
Lorena Lúcia Costa Ladeira ◽  
Sarah Pereira Martins ◽  
Cayara Mattos Costa ◽  
Elizabeth Lima Costa ◽  
Rubenice Amaral da Silva ◽  
...  

Biometrics ◽  
2015 ◽  
Vol 71 (2) ◽  
pp. 299-301 ◽  
Author(s):  
Olli Saarela ◽  
David A. Stephens ◽  
Erica E. M. Moodie ◽  
Marina B. Klein

Biostatistics ◽  
2018 ◽  
Vol 21 (1) ◽  
pp. 172-185 ◽  
Author(s):  
Pål Christie Ryalen ◽  
Mats Julius Stensrud ◽  
Sophie Fosså ◽  
Kjetil Røysland

Abstract In marginal structural models (MSMs), time is traditionally treated as a discrete parameter. In survival analysis on the other hand, we study processes that develop in continuous time. Therefore, Røysland (2011. A martingale approach to continuous-time marginal structural models. Bernoulli 17, 895–915) developed the continuous-time MSMs, along with continuous-time weights. The continuous-time weights are conceptually similar to the inverse probability weights that are used in discrete time MSMs. Here, we demonstrate that continuous-time MSMs may be used in practice. First, we briefly describe the causal model assumptions using counting process notation, and we suggest how causal effect estimates can be derived by calculating continuous-time weights. Then, we describe how additive hazard models can be used to find such effect estimates. Finally, we apply this strategy to compare medium to long-term differences between the two prostate cancer treatments radical prostatectomy and radiation therapy, using data from the Norwegian Cancer Registry. In contrast to the results of a naive analysis, we find that the marginal cumulative incidence of treatment failure is similar between the strategies, accounting for the competing risk of other death.


Sign in / Sign up

Export Citation Format

Share Document